Robert J Harvey Selected Research

Glycine (Aminoacetic Acid)

1/2022	Loss, Gain and Altered Function of GlyR α2 Subunit Mutations in Neurodevelopmental Disorders.
11/2021	Glycine Transporters and Receptors as Targets for Analgesics.
1/2016	Murine startle mutant Nmf11 affects the structural stability of the glycine receptor and increases deactivation.
11/2013	Glycine transporters as novel therapeutic targets in schizophrenia, alcohol dependence and pain.
1/2009	Glycinergic transmission in the Mammalian retina.
1/2008	A critical role for glycine transporters in hyperexcitability disorders.
2/2007	Diversity of glycine receptors in the mouse retina: localization of the alpha4 subunit.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert J Harvey Research Topics

Disease

17	Hyperekplexia 01/2022 - 07/2003
7	Pain (Aches) 10/2022 - 05/2004
6	Epilepsy (Aura) 01/2020 - 01/2004
6	Intellectual Disability (Idiocy) 01/2019 - 06/2010
5	Parkinson Disease (Parkinson's Disease) 01/2018 - 11/2005
5	Seizures (Absence Seizure) 01/2017 - 09/2010
4	Autism Spectrum Disorder 01/2022 - 01/2017
3	Neurodevelopmental Disorders 07/2023 - 01/2015
3	Inflammation (Inflammations) 01/2009 - 05/2004
2	Scabies (Sarcoptic Mange) 01/2023 - 03/2022
2	Chronic Pain 10/2022 - 11/2021
2	Alcoholism (Alcohol Abuse) 01/2020 - 11/2013
2	Myoclonus (Nocturnal Myoclonus) 01/2016 - 01/2013
2	Stiff-Person Syndrome (Stiff Man Syndrome) 01/2016 - 01/2013
2	Progressive Encephalomyelitis with Rigidity 01/2016 - 01/2013
2	Ganglion Cysts (Ganglion) 01/2009 - 02/2007
2	Neuralgia (Stump Neuralgia) 01/2009 - 12/2006
2	Nervous System Diseases (Neurological Disorders) 01/2008 - 07/2006
2	Lissencephaly 11/2007 - 01/2007
1	Mite Infestations (Mange) 04/2024
1	Developmental Disabilities (Developmental Disability) 07/2023
1	Neoplasms (Cancer) 01/2022
1	Myoclonic Epilepsies (Myoclonic Encephalopathy) 01/2020
1	Autistic Disorder (Autism) 01/2018
1	Lethargy 01/2017
1	Ataxia (Dyssynergia) 01/2017
1	Tremor (Tremors) 01/2016
1	Brain Diseases (Brain Disorder) 09/2015
1	Multiple Sclerosis 02/2015
1	Optic Neuritis (Retrobulbar Neuritis) 02/2015
1	Neuromyelitis Optica (Devic's Disease) 02/2015
1	Infections 01/2015
1	Infantile Spasms (West Syndrome) 01/2014
1	Partial Epilepsies (Epilepsy, Partial) 01/2014
1	Peripheral Nervous System Diseases (PNS Diseases) 11/2013
1	Schizophrenia (Dementia Praecox) 11/2013
1	Optic Atrophy 01/2013
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2013
1	Dyspnea (Shortness of Breath) 01/2011
1	Starvation 01/2011
1	Apnea 11/2010
1	Brain Stem Infarctions (Weber Syndrome) 11/2010

Drug/Important Bio-Agent (IBA)

17	Glycine Receptors (Glycine Receptor)IBA 10/2022 - 07/2003
7	Proteins (Proteins, Gene)FDA Link 07/2023 - 07/2003
7	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2022 - 02/2007
6	gephyrinIBA 01/2019 - 07/2003
4	DNA (Deoxyribonucleic Acid)IBA 01/2015 - 07/2010
4	Glycine Plasma Membrane Transport ProteinsIBA 03/2013 - 07/2006
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2020 - 01/2014
3	glycine receptor alpha3 subunitIBA 01/2009 - 05/2004
2	moxidectinIBA 04/2024 - 03/2022
2	AcaricidesIBA 04/2024 - 01/2023
2	Opioid Analgesics (Opioids)IBA 10/2022 - 11/2010
2	AutoantibodiesIBA 01/2016 - 01/2013
2	Phosphotransferases (Kinase)IBA 03/2011 - 11/2007
2	Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA 09/2010 - 06/2010
2	Nonsense Codon (Nonsense Mutation)IBA 01/2010 - 07/2006
2	GABA-A Receptors (GABA(A) Receptor)IBA 01/2009 - 09/2008
2	TubulinIBA 11/2007 - 01/2007
2	Dinoprostone (PGE2)FDA Link 12/2006 - 05/2004
1	A1443 compoundIBA 04/2024
1	HeterochromatinIBA 07/2023
1	ChromatinIBA 07/2023
1	Dosage Forms (Dosage Form)IBA 01/2023
1	Analgesics (Analgesic Drugs)IBA 10/2022
1	MetalsIBA 01/2022
1	Methionine (L-Methionine)FDA Link 01/2020
1	CarbonIBA 01/2020
1	CannabidiolIBA 01/2020
1	CationsIBA 01/2020
1	Dopamine (Intropin)FDA LinkGeneric 01/2020
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2019
1	LigandsIBA 01/2018
1	AnionsIBA 01/2018
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2018
1	Phenobarbital (Luminal)FDA Link 01/2017
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2017
1	Levetiracetam (Keppra)FDA LinkGeneric 01/2017
1	DNA Transposable Elements (Element, IS)IBA 01/2017
1	Pentylenetetrazole (Metrazol)IBA 01/2017
1	Lysine (L-Lysine)FDA Link 01/2016
1	mitochondrial ATPase subunit cIBA 01/2016
1	AsparagineIBA 01/2016
1	Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA 01/2016
1	ChloridesIBA 09/2015
1	AntibodiesIBA 02/2015
1	Aquaporin 4IBA 02/2015
1	Myelin-Oligodendrocyte GlycoproteinIBA 02/2015
1	LactamsIBA 01/2015
1	epicatechin gallateIBA 01/2015
1	PolyphenolsIBA 01/2015
1	Glutamic Acid (Glutamate)FDA Link 01/2014
1	Ion Channels (Ion Channel)IBA 01/2014
1	N-Methylaspartate (NMDA)IBA 01/2014
1	SteroidsIBA 01/2013
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2013
1	Immunoglobulin G (IgG)IBA 01/2013
1	molybdopterin (molybdenum cofactor)IBA 01/2011
1	Opioid Receptors (Opioid Receptor)IBA 11/2010

Therapy/Procedure

2	Therapeutics 10/2022 - 05/2004